"The physician interviews and secondary published research conducted by associates of Halpern Info Services focused on our in-vivo, real-time, optical cancer detection technology. The use of professional researchers was valuable in helping Optimum Technologies validate and prioritize the market opportunity, and in making the decision to move ahead and commercialize our new offering using the technique of Elastic Scattering Spectroscopy (ESS).

Randy Chinnock, CEO & Founder, Optimum Technologies, Inc.